Atıf İçin Kopyala
Ozdemir F., DEMİRBÜGEN ÖZ M., SÜZEN H. S.
CURRENT DRUG METABOLISM, cilt.20, sa.10, ss.845-851, 2019 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
20
Sayı:
10
-
Basım Tarihi:
2019
-
Doi Numarası:
10.2174/1389200220666190913121052
-
Dergi Adı:
CURRENT DRUG METABOLISM
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.845-851
-
Anahtar Kelimeler:
CYP oxidoreductase, POR*28, A503V, Turkish, PCR-RFLP, pharmacogenetics, metabolism, OXIDOREDUCTASE GENETIC POLYMORPHISMS, HUMAN P450 OXIDOREDUCTASE, ACTIVITY IN-VIVO, CYTOCHROME-P450, CYP3A, TACROLIMUS, PHARMACOKINETICS, VARIANTS, IMPACT, CYP3A4-ASTERISK-22
-
Ankara Üniversitesi Adresli:
Evet
Özet
Background: The Cytochrome P450 (CYP) enzymes are involved in the metabolism of many endogenous and exogenous substances. They need electrons for their activity. CYP mediated oxidation reactions require cytochrome oxidoreductase (POR) as an electron donor. A common genetic variation identified in the coding region of POR gene (POR*28) leads to an alteration in POR activity by causing amino acid change. The current study aimed to determine the allele and genotype frequencies of POR*28 in a healthy Turkish population by using a novel genotyping assay.